KRAS and cancer: Here, using MD simulations, we provided structural insights into how K-Ras4B dual Y32 and Y64 phosphorylation regulated by Src/SHP2 could influence its activities, thereby motivating progress in targeting Ras phosphorylation for cancer drug discovery.